Related references
Note: Only part of the references are listed.Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects
Guoxin Wu et al.
CLINICAL BIOCHEMISTRY (2008)
Type III neuregulin-1 promotes oligodendrocyte myelination
Carla Taveggia et al.
GLIA (2008)
Aspects of β-amyloid as a biomarker for Alzheimer's disease
Ulf Andreasson et al.
BIOMARKERS IN MEDICINE (2007)
Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides
Krystyn Z. Bourne et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation
Xian Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cerebrospinal fluid protein reactions during non-neurological surgery
R. Anckarsater et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
Control of peripheral nerve myelination by the β-secretase BACE1
Michael Willem et al.
SCIENCE (2006)
High cholesterol content in neurons increases BACE, β-amyloid, and phosphorylated tau levels in rabbit hippocampus
Othman Ghribi et al.
EXPERIMENTAL NEUROLOGY (2006)
Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function
S Chen et al.
JOURNAL OF NEUROSCIENCE (2006)
Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
M Sastre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Transcriptional and translational regulation of BACE1 expression - Implications for Alzheimer's disease
Steffen Rossner et al.
PROGRESS IN NEUROBIOLOGY (2006)
BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions
FM Laird et al.
JOURNAL OF NEUROSCIENCE (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Axonal neuregulin-1 regulates myelin sheath thickness
GV Michailov et al.
SCIENCE (2004)
Cerebrospinal fluid markers in MS patients and their healthy siblings
S Haghighi et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement
E Trysberg et al.
ARTHRITIS AND RHEUMATISM (2003)
Interferon γ stimulates β-secretase expression and sAPPβ production in astrocytes
HS Hong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage
T Owens
CURRENT OPINION IN NEUROLOGY (2003)
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
